Clinical Trials & Tissue Testing for Biotechnology & Pharmaceutical Companies


As a medical oriented company, we are committed to service, research and science. 


Patho-Lab Diagnostics is approved to be in compliance to OECD Principles of Good Laboratory Practice (GLP) according to directive 88/320/EEC in Histopathology testing by the Israel Laboratory Accreditation Authority (ISRAC). 

OECD- The Organization for Economic Cooperation & development, part of the World Trade Organization (WTO). 

The accreditation is fully accepted internationally by the FDA and other international regulators. 


We employ a full time skilled biologist project coordinator who does not only facilitate work flow and efficiency but also suggests innovations, or improved methods for required questions. 


Our research projects team can provide advice regarding any laboratory related aspect of your studies after signing confidentiality agreement.


Dozens of biologically oriented academic institutions worldwide, as well as Pharmaceutical and Biotech Companies are engaged with Patho-Lab Diagnostics in a wide variety of clinical trials, experimental research (GLP and non-GLP) projects such as micro-vascular injectors' efficacy, verification of cancer animal models, cancer treatment, validation of new antibodies, stent research, orthopedic prothesis and implants. 


Our research unit has an ongoing commitment to external and internal quality control, assuring the validity of processes and results. 


The company owns thousands of human cancer and non-cancer tissue paraffin blocks and receives and processes hundreds of new samples weekly. 

This endless resource of potential research materials is one of the unique and greatest assets of our laboratories handled according the strict regulations of the Israeli law. 


Please contact us for more details.